Chaperone Therapeutics Inc - NC Durham, Durham 27709

Chaperone Therapeutics Inc entered the industry of Medical Research in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417112, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Maria Sippola-Thiele, Chief Executive Officer by calling (919) 933-5627 during business hours. You can also write to the business’ Single Location at 6 Davis Drive, Durham, North Carolina NC 27709. You can also visit the company’s website at chaperonetherapeutics.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Chaperone Therapeutics Inc
Representative: Maria Sippola-Thiele, Chief Executive Officer
Place of Business: 6 Davis Drive, Durham, NC 27709
Contact Number: (919) 933-5627
Website: chaperonetherapeutics.com
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 5417112
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2009
Income/Year: Unknown
Laborers: 1 to 4
Share This Company:

Chaperone Therapeutics Inc is a company operating from Durham, North Carolina providing professional Medical Research and relevant B2B variables. It was founded in 2009 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 5417112 as Medical Research.

With a current employee count of 1 to 4, Chaperone Therapeutics Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Maria Sippola-Thiele, Chief Executive Officer at (919) 933-5627 for related queries, or to locate its Single Location using the coordinates 35.90105,-78.85852.

The Single Location can also be found at the street address 6 Davis Drive in Durham, North Carolina 27709 and can be engaged online through the company website at chaperonetherapeutics.com, the company Twitter , and Facebook page .